Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Lactobacillus gasseri G098 Strain Mitigates Symptoms of DSS-Induced Inflammatory Bowel Disease in Mice

10 Sept 2022

Abstract excerpt

Inflammatory bowel disease (IBD) is a recurring inflammatory disease of the gastrointestinal tract with unclear etiology, but it is thought to be related to factors like immune abnormalities and gut microbial dysbiosis. Probiotics can regulate host immunity and gut microbiota; thus, we investigated the alleviation effect and mechanism of the strain Lactobacillus gasseri G098 (G098) on dextran sodium sulfate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastrointestinal motility and disorders
Share to Gut microbiota and health
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36145120
DOI: 10.3390/nu14183745

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Lactobacillus gasseri G098 Strain Mitigates Symptoms of DSS-Induced Inflammatory Bowel Disease in MicePMID 36145120Read ↗

Immunomodulatory Effects of a Probiotic Mixture: Alleviating Colitis in a Mouse Model through Modulation of Cell Activation Markers and the Gut MicrobiotaSemantic proximity Read ↗

Dynamic Changes in Gut Microbiome of Ulcerative Colitis: Initial Study from Animal ModelSemantic proximity Read ↗

Alleviation of DSS-induced colitis via Lactobacillus acidophilus treatment in miceSemantic proximity Read ↗

Enhancing Recovery from Gut Microbiome Dysbiosis and Alleviating DSS-Induced Colitis in Mice with a Consortium of Rare Short-Chain Fatty Acid-Producing BacteriaSemantic proximity Read ↗

Enhancing recovery from gut microbiome dysbiosis and alleviating DSS-induced colitis in mice with a consortium of rare short-chain fatty acid-producing bacteriaSemantic proximity Read ↗

Gut microbiota in ulcerative colitis: insights on pathogenesis and treatmentSemantic proximity Read ↗

Probiotics (Lactiplantibacillus plantarum HNU082) supplementation relieves ulcerative colitis by affecting intestinal barrier functions, immunity-related genes expression, gut microbiota, and metabolic pathways in miceSemantic proximity Read ↗

Modulation of gut microbiota and anti-inflammatory effect of a probiotic cocktail in an inflammatory bowel disease-induced mouse model by fecal transplantationSemantic proximity Read ↗

Lacidophilin Modulated Gut Microbiota and Ameliorated Dextran Sulfate Sodium-Induced Mouse ColitisSemantic proximity Read ↗

Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel diseaseSemantic proximity Read ↗

Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profileSemantic proximity Read ↗

Modulation of Gut Microbiota and Immune System by Probiotics, Pre-biotics, and Post-bioticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.